SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 87, Issue 4 SUPPL. 1, 2001, Pages 1-7

Introduction: Utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents

(1) Davidson, Michael H a,b

a RADIANT RESEARCH (United States)

b RUSH UNIVERSITY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PLACEBO; SIMVASTATIN;

ATHEROGENESIS; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; COST BENEFIT ANALYSIS; DISEASE MARKER; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0035895645 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9149(01)01418-7 Document Type: Article

Times cited : (12)

References (9)

1
- 0027243348
- Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
- (1993) JAMA , vol.269 , pp. 3015-3023

2
- 0033973897
- Cholesterol management in the era of managed care
- (2000) Am J Cardiol , vol.85 , Issue.SUPPL. 3A
- Grundy, S.M.¹

3
- 0030469986
- Peripheral artery disease and cardiovascular risk factors in the elderly: The Honolulu Heart Program
- (1996) Arterioscler Thromb Vasc Biol , vol.16 , pp. 1495-1500
- Curb, J.D.¹ Masaki, K.² Rodriguez, B.L.³ Abbott, R.D.⁴ Burchfiel, C.M.⁵ Chen, R.⁶ Petrovitch, H.⁷ Sharp, D.⁸ Yano, K.⁹

4
- 0032554686
- Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
- (1998) Circulation , vol.97 , pp. 1453-1460
- Pedersen, T.R.¹ Olsson, A.G.² Faergeman, O.³ Kjekshus, J.⁴ Wedel, H.⁵ Berg, K.⁶ Wilhelmsen, L.⁷ Haghfelt, T.⁸ Thorgeirsson, G.⁹ Pyorala, K.¹⁰

5
- 0342879940
- Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
- (2000) Circulation , vol.101 , pp. 477-484
- Gotto A.M., Jr.¹ Whitney, E.² Stein, E.A.³ Shapiro, D.R.⁴ Clearfield, M.⁵ Weis, S.⁶ Jou, J.Y.⁷ Langendorfer, A.⁸ Beere, P.A.⁹ Watson, D.J.¹⁰ Downs, J.R.¹¹ De Cani, J.S.¹²

6
- 0032547326
- Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
- (1998) JAMA , vol.280 , pp. 605-613
- Hulley, S.¹ Grady, D.² Bush, T.³ Furberg, C.⁴ Herrington, D.⁵ Riggs, B.⁶ Vittinghoff, E.⁷

7
- 2642712522
- Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
- (1998) JAMA , vol.279 , pp. 1445-1451
- Walsh, B.W.¹ Kuller, L.H.² Wild, R.A.³ Paul, S.⁴ Farmer, M.⁵ Lawrence, J.B.⁶ Shah, A.S.⁷ Anderson, P.W.⁸

8
- 0034640040
- Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause
- (2000) JAMA , vol.283 , pp. 1845-1852
- Shlipak, M.G.¹ Simon, J.A.² Vittinghoff, E.³ Lin, F.⁴ Barrett-Connor, E.⁵ Knopp, R.H.⁶ Levy, R.I.⁷ Hulley, S.B.⁸

9
- 0006008665
- Low density lipoprotein subclass distribution pattern does not modify serum lipid and apolipoprotein responses to hormone replacement therapy
- Oct
- (1999) Proceedings, 9th International Menopause Society World Congress on the Menopause
- Maki, K.C.¹ Davidson, M.H.² Marx, P.³ Cyrowski, M.⁴ Maki, A.C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.